Metagenomi Showcases Advanced AI-Enhanced Gene Editing for Neurological Disorders at ASGCT Meeting

Why is Opendoor stock surging again? How did Trump tariffs impact Stellantis profits? What caused Microsoft SharePoint cyberattacks? Why is Figma targeting a $16 billion IPO valuation? How will EU respond to US trade tariffs? Why did LVMH invest in Flexjet? What drives Nvidia's $4 trillion valuation?

Metagenomi Showcases Advanced AI-Enhanced Gene Editing for Neurological Disorders at ASGCT Meeting

finance.yahoo.com/news/metagenomi-showcases-advanced-ai-enhanced-151200191.html

In This Article:
Metagenomi Inc. (NASDAQ:MGX) is one of the best young stocks to buy and hold for 5 years. In mid-May, Metagenomi announced the presentation of 3 abstracts at the American Society of Gene & Cell Therapy/ASGCT 28th Annual Meeting, which was held from May 13 to 17 in New…

This story appeared on finance.yahoo.com, 2025-07-14 15:12:00.